Article

Daily OTC Pearl: Vazalore

Vazalore has been shown to cause fewer stomach-related adverse effects than traditional aspirin.

OTC/Lifestyle Pearl of the Day: Vazalore

Indication: Valazore, a new type of aspirin, is a non-steroidal anti-inflammatory drug approved by the FDA in March 2021 as an OTC product that helps prevent blood clots.

Insight:

  • Classified as a salicylate.
  • Compared to traditional aspirin, Vazalore has been shown to cause fewer stomach-related adverse effects, such as ulcers and damage to the stomach.
  • Dosing: Coronary artery bypass graft 325 mg once daily (start 6 hours after procedure) for 1 year. Percutaneous transluminal coronary angioplasty 325 mg 2 hours before surgery, then 160 mg–325 mg once daily. Carotid endarterectomy 80 mg once daily to 650 mg twice daily (start before surgery).
  • The higher dose of Vazalore (325 mg) works by blocking certain chemicals in the body that cause pain, fever, and swelling.
  • Caution: Do not take if history of bleeding and speak to the provider before starting the medication.
  • If pregnant, discuss the use of Vazalore with a health care provider first.
  • Available dosage: Caps 81 mg—12, 30; 325 mg—30.

Sources:

What Are the Differences Between Vazalore and OTC Aspirin? - GoodRx

VAZALORE Dosage & Rx Info | Uses, Side Effects (empr.com)

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com